China
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
29.31%
|
Dec. 31, 2023 | USD 3.32 | -1.00% |
|
China |
|
2 |
25.44%
|
Dec. 31, 2023 | USD 7.81 | 1.73% |
|
China |
|
3 |
24.45%
|
Dec. 31, 2023 | USD 3.80 | 1.71% |
|
China |
|
4 |
19.33%
|
Dec. 31, 2023 | USD 2.09 | 0.57% |
|
China |
|
5 |
18.66%
|
Dec. 31, 2023 | USD 4.81 | -0.80% |
|
China |
|
6 |
16.41%
|
Dec. 31, 2023 | USD 7.07 | -1.23% |
|
China |
|
7 |
16.16%
|
Dec. 31, 2023 | USD 0.47 | 3.66% |
|
China |
|
8 |
16.13%
|
Dec. 31, 2023 | USD 2.35 | 0.02% |
|
China |
|
9 |
16.04%
|
Dec. 31, 2023 | USD 2.03 | -0.16% |
|
China |
|
10 |
15.65%
|
Dec. 31, 2023 | USD 2.18 | 0.29% |
|
China |
|
11 |
15.65%
|
Dec. 31, 2023 | USD 1.35 | 1.98% |
|
China |
|
12 |
14.74%
|
Dec. 31, 2023 | USD 2.68 | -1.51% |
|
China |
|
13 |
14.65%
|
Dec. 31, 2023 | USD 3.38 | -0.40% |
|
China |
|
14 |
14.64%
|
Dec. 31, 2023 | USD 2.28 | 1.94% |
|
China |
|
15 |
13.99%
|
Dec. 31, 2023 | USD 3.06 | -1.56% |
|
China |
|
16 |
13.96%
|
Dec. 31, 2023 | USD 2.88 | 0.58% |
|
China |
|
17 |
12.04%
|
Dec. 31, 2023 | USD 0.51 | -0.09% |
|
China |
|
18 |
11.91%
|
Dec. 31, 2023 | USD 1.85 | -1.20% |
|
China |
|
19 |
11.48%
|
Dec. 31, 2023 | USD 2.15 | -0.48% |
|
China |
|
20 |
11.01%
|
Dec. 31, 2023 | USD 0.77 | -3.24% |
|
China |
|
21 |
10.80%
|
Dec. 31, 2023 | USD 2.45 | -0.43% |
|
China |
|
22 |
10.74%
|
Dec. 31, 2023 | USD 9.39 | -0.63% |
|
China |
|
23 |
10.74%
|
Dec. 31, 2023 | USD 0.87 | 1.51% |
|
China |
|
24 |
10.73%
|
Dec. 31, 2023 | USD 1.31 | 1.38% |
|
China |
|
25 |
10.21%
|
Dec. 31, 2023 | USD 3.70 | -0.36% |
|
China |
|
26 |
9.99%
|
Dec. 31, 2023 | USD 3.68 | -0.21% |
|
China |
|
27 |
9.16%
|
Dec. 31, 2023 | USD 2.85 | 1.73% |
|
China |
|
28 |
8.55%
|
Dec. 31, 2023 | USD 1.98 | -1.19% |
|
China |
|
29 |
8.30%
|
Dec. 31, 2023 | USD 3.39 | 4.94% |
|
China |
|
30 |
8.20%
|
Dec. 31, 2023 | USD 1.44 | -2.25% |
|
China |
|
31 |
7.93%
|
Dec. 31, 2023 | USD 3.12 | -1.05% |
|
China |
|
32 |
7.77%
|
Dec. 31, 2023 | USD 0.84 | -0.59% |
|
China |
|
33 |
7.77%
|
Dec. 31, 2023 | USD 2.25 | -5.87% |
|
China |
|
34 |
7.43%
|
Dec. 31, 2023 | USD 0.96 | 0.77% |
|
China |
|
35 |
7.38%
|
Dec. 31, 2023 | USD 1.63 | -0.18% |
|
China |
|
36 |
7.35%
|
Dec. 31, 2023 | USD 6.71 | 0.24% |
|
China |
|
37 |
7.27%
|
Dec. 31, 2023 | USD 11.02 | -1.67% |
|
China |
|
38 |
7.10%
|
Dec. 31, 2023 | USD 1.70 | 0.39% |
|
China |
|
39 |
6.58%
|
Dec. 31, 2023 | USD 3.08 | 0.94% |
|
China |
|
40 |
5.82%
|
Dec. 31, 2023 | USD 2.78 | -1.27% |
|
China |
|
41 |
5.39%
|
Dec. 31, 2023 | USD 1.92 | -0.31% |
|
China |
|
42 |
5.20%
|
Dec. 31, 2023 | USD 0.91 | 1.13% |
|
China |
|
43 |
5.04%
|
Dec. 31, 2023 | USD 2.34 | -1.60% |
|
China |
|
44 |
5.02%
|
Dec. 31, 2023 | USD 5.28 | -0.15% |
|
China |
|
45 |
5.01%
|
Dec. 31, 2023 | USD 1.54 | -1.68% |
|
China |
|
46 |
4.86%
|
Dec. 31, 2023 | USD 0.99 | 4.41% |
|
China |
|
47 |
4.81%
|
Dec. 31, 2023 | USD 4.00 | -0.23% |
|
China |
|
48 |
4.24%
|
Dec. 31, 2023 | USD 0.30 | -0.45% |
|
China |
|
49 |
3.69%
|
Dec. 31, 2023 | USD 0.38 | -0.45% |
|
China |
|
50 |
3.62%
|
Dec. 31, 2023 | USD 3.31 | 1.64% |
|
China |
The Vaccines company in China with the highest Return on Capital Employed (ROCE) is Chongqing Zhifei Biological Products Co., Ltd. (Shenzhen Stock Exchange: 300122.SZ) at 29.31%.
The Vaccines company in China with the lowest Return on Capital Employed (ROCE) is Fujian Aonong Biological Technology Group Incorporation Limited (Shanghai Stock Exchange: 603363.SS) at -117.65%.
The top 10 Vaccines companies in China by Return on Capital Employed (ROCE) are Chongqing Zhifei Biological Products Co., Ltd., Akeso, Inc., Hubei Jumpcan Pharmaceutical Co., Ltd., Apeloa Pharmaceutical Co.,Ltd, Beijing Sun-Novo Pharmaceutical Research Co., Ltd., Chengdu Kanghua Biological Products Co., Ltd., HBM Holdings Limited, Hualan Biological Bacterin Inc., Zhejiang Jolly Pharmaceutical Co.,LTD and Hualan Biological Engineering Inc..
The bottom 10 Vaccines companies in China by Return on Capital Employed (ROCE) are Fujian Aonong Biological Technology Group Incorporation Limited, Burning Rock Biotech Limited, Tech-Bank Food Co., Ltd., Connect Biopharma Holdings Limited, I-Mab, Ascentage Pharma Group International, Genor Biopharma Holdings Limited, ImmuneOnco Biopharmaceuticals (Shanghai) Inc., AIM Vaccine Co., Ltd. and Zai Lab Limited.